CAYSTON 75 mg, powder and solvent for solution for inhalation by nebulizer 84 bottles
Active ingredients: Aztreonam, Aztreonam lysine
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for inhalation by nebulizer84 bottlesinhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CAYSTON 75 mg, poudre et solvant pour solution pour inhalation par nébiliseur
- Pharmaceutical form
- poudre et solvant pour solution pour inhalation par nébuliseur
- Route of administration
- inhalée
- Presentation description
- 84 flacon(s) en verre - 88 ampoule(s) polyéthylène basse densité (PEBD) avec nébulisateur Altera
- Marketing authorisation holder
- GILEAD SCIENCES IRELAND UC (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 10 May 2010
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61054849CIP73751511CIP133400937515115Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| AZTRÉONAM DE LYSINEpoudre | 121,7 mg · un flacon de poudre | SA |
| AZTRÉONAMpoudre | 75 mg · un flacon de poudre | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.